Subacute and chronic effects of quinapril on cardiac cytokine expression, remodeling, and function after myocardial infarction in the rat

Journal of Cardiovascular Pharmacology

Volumn 39, Issue 6, 2002, Pages 842-850

  Wei, Ge Cheng ^a   Sirois, Martin G ^a   Qu, Rong ^a   Liu, Peter ^a   Rouleau, Jean L ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Angiotensin converting enzyme inhibitors; Cytokines; Heart failure; Infarction; Remodeling

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INTERLEUKIN 1BETA; INTERLEUKIN 5; INTERLEUKIN 6; QUINAPRIL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONOTHERAPY; CONTROLLED STUDY; CORONARY ARTERY LIGATION; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; HEART HEMODYNAMICS; HEART INFARCTION; HEART VENTRICLE REMODELING; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CYTOKINES; ISOQUINOLINES; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; RATS, WISTAR; SURVIVAL RATE; TETRAHYDROISOQUINOLINES; VENTRICULAR REMODELING;

EID: 0036116880     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200206000-00009     Document Type: Article

References (40)

1. New targets for heart-failure therapy: Endothelin, inflammatory cytokines, and oxidative stress
2. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart
3. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the Studies of Left Ventricular Dysfunction (SOLVD)
4. TNF-α heart failure the difference between proof of principle and hypothesis testing
5. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure
6. Role of cytokines in the mechanism of action of amlodipine: The PRAISE heart failure trial
7. Cytokines and cardiac contractile function
8. Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats
9. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-α
10. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-α
11. Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart
12. Pathophysiological role of cytokines in congestive heart failure
13. Negative inotrope effects of cytokines on the heart mediated by nitric oxide
14. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte β-adrenergic responsiveness
15. Cytokine gene expression after myocardial infarction in rat hearts
16. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes
17. Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cell in vitro
18. Comparison of tumour necrosis-alpha effect on expression of iNOS in macrophages and cardiac myocytes
19. Stress activated cytokines and the heart
20. Level of T-level lymphocyte subpopulations, interleukin-1 beta, and soluble interleukin-2 receptor in acute myocardial infarction
21. Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium
22. Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure
23. Indications for ACE inhibitors in the early treatment of acute myocardial infarction: Systematic overview of individual data from 100 000 patients in randomized trials
24. ACE inhibitors in acute myocardial infarction patient selection and timing
25. ACE inhibitor quinapril reduces the arterial expression of NF-kappaB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis
26. The effect of renin-angiotensin system inhibitors on pro- and anti-inflammatory cytokine production
27. Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors
28. Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-α and angiotensin II
29. Angiotensin II augments cytokine-stimulated nitric oxide synthesis in rat cardiac myocytes
30. Hypoxic stress induces cardiac myocyte-derived interleukin-6
31. Hemodynamic regulation of tumor necrosis factor-α gene and protein expression in adult feline myocardium
32. Endothelin A receptor blockade causes adverse left ventricular remodeling but improves pulmonary artery pressure after infarction in the rat
33. Relevance of blockade of cardiac and circulatory angiotensin converting enzyme for the prevention of volume overload-induced cardiac hypertrophy
34. Influence of chronic captopril therapy on the infarcted left ventricle of the rat
35. Markedly different effects on ventricular remodeling result in a decrease in inducibility of ventricular arrhythmias
36. Quantitative two dimensional echocardiographic measurements are major predictors of adverse cardiovascular events, following acute myocardial infarction: The protective effects of captopril
37. Angiotensin II signal transduction in vascular smooth muscle
38. Mechanism by which quinapril improves vascular function in coronary artery disease
39. Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy
40. Endothelin-1 stimulates the biosynthesis of tumor necrosis factor in macrophages: ET-receptors. Signal transduction and inhibition by dexamethasone